These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9311844)

  • 1. Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.
    Bruder JT; Jie T; McVey DL; Kovesdi I
    J Virol; 1997 Oct; 71(10):7623-8. PubMed ID: 9311844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo.
    Schowalter DB; Tubb JC; Liu M; Wilson CB; Kay MA
    Gene Ther; 1997 Apr; 4(4):351-60. PubMed ID: 9176522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
    Lee MG; Abina MA; Haddada H; Perricaudet M
    Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes.
    Hermiston TW; Tripp RA; Sparer T; Gooding LR; Wold WS
    J Virol; 1993 Sep; 67(9):5289-98. PubMed ID: 8350398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.
    Sparer TE; Tripp RA; Dillehay DL; Hermiston TW; Wold WS; Gooding LR
    J Virol; 1996 Apr; 70(4):2431-9. PubMed ID: 8642671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K.
    Rawle FC; Tollefson AE; Wold WS; Gooding LR
    J Immunol; 1989 Sep; 143(6):2031-7. PubMed ID: 2789254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The signal-anchor domain of adenovirus E3-6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum.
    Wilson-Rawls J; Deutscher SL; Wold WS
    Virology; 1994 May; 201(1):66-76. PubMed ID: 8178490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates.
    Hermiston TW; Hellwig R; Hierholzer JC; Wold WS
    Virology; 1993 Dec; 197(2):593-600. PubMed ID: 8249282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
    Bortolanza S; Bunuales M; Alzuguren P; Lamas O; Aldabe R; Prieto J; Hernandez-Alcoceba R
    Cancer Gene Ther; 2009 Sep; 16(9):703-12. PubMed ID: 19229289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver.
    Lieber A; He CY; Meuse L; Himeda C; Wilson C; Kay MA
    J Virol; 1998 Nov; 72(11):9267-77. PubMed ID: 9765474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo.
    Brough DE; Hsu C; Kulesa VA; Lee GM; Cantolupo LJ; Lizonova A; Kovesdi I
    J Virol; 1997 Dec; 71(12):9206-13. PubMed ID: 9371579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.
    Wold WS; Gooding LR
    Mol Biol Med; 1989 Oct; 6(5):433-52. PubMed ID: 2533958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.
    Jooss K; Ertl HC; Wilson JM
    J Virol; 1998 Apr; 72(4):2945-54. PubMed ID: 9525615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
    Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
    J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.
    Kaplan JM; Armentano D; Sparer TE; Wynn SG; Peterson PA; Wadsworth SC; Couture KK; Pennington SE; St George JA; Gooding LR; Smith AE
    Hum Gene Ther; 1997 Jan; 8(1):45-56. PubMed ID: 8989994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.
    Harrod KS; Hermiston TW; Trapnell BC; Wold WS; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(13):1885-98. PubMed ID: 9741427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.